Literature DB >> 10364338

Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages.

S Worgall1, R Connor, R J Kaner, E Fenamore, K Sheridan, R Singh, R G Crystal.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) requires, in addition to CD4, coreceptors of the CC or CXC chemokine families for productive infection of T cells and cells of the monocyte-macrophage lineage. Based on the hypothesis that coreceptor expression on alveolar macrophages (AM) may influence HIV-1 infection of AM in the lung, this study analyzes the expression and utilization of HIV-1 coreceptors on AM of healthy individuals. AM were productively infected with five different primary isolates of HIV-1. Levels of surface expression of CCR5, CXCR4, and CD4 were low compared to those of blood monocytes, but CCR3 was not detectable. mRNA for CCR5, CXCR4, CCR2, and CCR3 were all detectable, but to varying degrees and with variability among donors. Expression of CCR5, CXCR4, and CCR2 mRNA was downregulated following stimulation with lipopolysaccharide (LPS). In contrast, secretion of the chemokines RANTES, MIP-1alpha, and MIP-1beta was upregulated with LPS stimulation. Interestingly, HIV-1 replication was diminished following LPS stimulation. Infection of AM with HIV-1 in the presence of the CC chemokines demonstrated blocking of infection. Together, these studies demonstrate that AM can be infected by a variety of primary HIV-1 isolates, AM express a variety of chemokine receptors, the dominant coreceptor used for HIV entry into AM is CCR5, the expression of these receptors is dependent on the state of activation of AM, and the ability of HIV-1 to infect AM may be modulated by expression of the chemokine receptors and by chemokines per se.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364338      PMCID: PMC112647     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection.

Authors:  A G Yang; X Bai; X F Huang; C Yao; S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.

Authors:  C C Bleul; L Wu; J A Hoxie; T A Springer; C R Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

3.  Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.

Authors:  S Rana; G Besson; D G Cook; J Rucker; R J Smyth; Y Yi; J D Turner; H H Guo; J G Du; S C Peiper; E Lavi; M Samson; F Libert; C Liesnard; G Vassart; R W Doms; M Parmentier; R G Collman
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

Authors:  G Simmons; P R Clapham; L Picard; R E Offord; M M Rosenkilde; T W Schwartz; R Buser; T N Wells; A E Proudfoot
Journal:  Science       Date:  1997-04-11       Impact factor: 47.728

5.  Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.

Authors:  G Simmons; D Wilkinson; J D Reeves; M T Dittmar; S Beddows; J Weber; G Carnegie; U Desselberger; P W Gray; R A Weiss; P R Clapham
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia.

Authors:  J He; Y Chen; M Farzan; H Choe; A Ohagen; S Gartner; J Busciglio; X Yang; W Hofmann; W Newman; C R Mackay; J Sodroski; D Gabuzda
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

7.  Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-A.

Authors:  L A Guay; J G Sierra-Madero; C K Finegan; E A Rich
Journal:  Am J Respir Cell Mol Biol       Date:  1997-04       Impact factor: 6.914

8.  C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells.

Authors:  A Verani; G Scarlatti; M Comar; E Tresoldi; S Polo; M Giacca; P Lusso; A G Siccardi; D Vercelli
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

9.  Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes.

Authors:  A Sica; A Saccani; A Borsatti; C A Power; T N Wells; W Luini; N Polentarutti; S Sozzani; A Mantovani
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

10.  Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.

Authors:  R I Connor; K E Sheridan; D Ceradini; S Choe; N R Landau
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

View more
  18 in total

1.  Leishmania infection impairs beta 1-integrin function and chemokine receptor expression in mononuclear phagocytes.

Authors:  Nathanael F Pinheiro; Micely D R Hermida; Mariana P Macedo; José Mengel; Andre Bafica; Washington L C dos-Santos
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Antiretroviral therapy in macrophages: implication for HIV eradication.

Authors:  Christina Gavegnano; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2009-10-19

Review 3.  The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.

Authors:  Sharilyn Almodovar
Journal:  Viral Immunol       Date:  2014-05-05       Impact factor: 2.257

4.  Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.

Authors:  Anthony R Geonnotti; Miroslawa Bilska; Xing Yuan; Christina Ochsenbauer; Tara G Edmonds; John C Kappes; Hua-Xin Liao; Barton F Haynes; David C Montefiori
Journal:  AIDS Res Hum Retroviruses       Date:  2010-03       Impact factor: 2.205

5.  Brain Microglial Cells Are Highly Susceptible to HIV-1 Infection and Spread.

Authors:  Jennifer J Cenker; Ryan D Stultz; David McDonald
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-26       Impact factor: 2.205

6.  Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.

Authors:  Hiromi Imamichi; Tatsuhiko Igarashi; Tomozumi Imamichi; Olivia K Donau; Yasuyuki Endo; Yoshiaki Nishimura; Ronald L Willey; Anthony F Suffredini; H Clifford Lane; Malcolm A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

7.  Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages.

Authors:  K Mori; M Rosenzweig; R C Desrosiers
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 8.  Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages.

Authors:  Kiyoko S Akagawa
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

9.  Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells.

Authors:  Marlynne Q Nicol; Jean-Marie Mathys; Albertina Pereira; Kevin Ollington; Michael H Ieong; Paul R Skolnik
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

10.  Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1.

Authors:  Vanessa Arfi; Lise Rivière; Loraine Jarrosson-Wuillème; Caroline Goujon; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.